Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Wave Life Sciences Usa, Inc.

Clinical trials sponsored by Wave Life Sciences Usa, Inc., explained in plain language.

Wave Life Sciences USA, Inc. WVE NASDAQ

A biotech company developing RNA-based therapies for genetic diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 2 Completed 1

RNA editing drug WVE-006 enters first human safety trial

Disease control Completed

This Phase 1 trial tested WVE-006, an RNA editing drug, in 47 healthy volunteers to see if it is safe and how the body processes it. The study is the first step toward a possible treatment for Alpha-1 antitrypsin deficiency, a genetic condition that can cause lung and liver disea…

Phase: PHASE1 • Sponsor: Wave Life Sciences USA, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC